Communiqués CONMED Corporation Deutsche Boerse AG

Actions

EC8

US2074101013

Equipement, fournitures et distribution médicale

Temps réel estimé Tradegate Autres places de cotation 21:40:07 29/07/2026			Varia. 5j.	Varia. 1 janv.
37,50 ^EUR	-2,85%		+3,83%	+8,57%

22/07	Conmed : le système AirSeal autorisé pour une utilisation avec la canule hexagonale du da Vinci 5 d'Intuitive	MT
14/07	L'action Conmed grimpe alors que la société envisage une vente face à l'intérêt de repreneurs	MT

Communiqués

23/07	CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula	AQ
22/07	CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula	BU
20/07	CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting	BU
02/07	CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026	BU
17/06	CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer	BU
20/05	CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors	BU
30/04	CONMED : Investor Presentation Q1 2026	PU
29/04	Conmed: Q1 Earnings Snapshot	AQ
29/04	CONMED Corporation Announces First Quarter 2026 Financial Results	BU
02/04	CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026	BU
28/01	Conmed: Q4 Earnings Snapshot	AQ
28/01	CONMED : Investor Presentation Q4 2025	PU
28/01	CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results	BU
12/01	CONMED : CNMD JPM Presentation 2026	PU
08/01	CONMED Corporation Announces Chief Financial Officer Transition	BU
05/01	CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference	BU
05/01	CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026	BU
05/12	CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines	BU
05/11	Conmed: Q3 Earnings Snapshot	AQ
05/11	CONMED : Investor Presentation Q3 2025	PU
05/11	CONMED Corporation Announces Third Quarter 2025 Financial Results	BU
02/10/25	CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025	BU
09/09/25	CONMED Corporation Adds Kim Kelderman to its Board of Directors	BU
11/08/25	CONMED Corporation Announces Quarterly Cash Dividend	AQ
08/08/25	CONMED Corporation Announces Quarterly Cash Dividend	BU